Cohort of IPF Patients Experiencing an Exacerbation

Extension of the PFBIO cohort which includes patients with newly diagnosed idiopathic pulmonary fibrosis (IPF) for longitudinal follow-up for up to 5 years. In the PFBIO-EXA extension, patients are included if they experience an exacerbation, or other increase in respiratory symptoms requiring hospital admission, for further collection of clinical and biological data.

NCT Number	NCT04442711
Lead Sponsor	University Hospital, Gentofte, Copenhagen
Conditions	Idiopathic Pulmonary Fibrosis
Enrollment	50 participants
Start Date	2020-06-13
Primary Completion	2027-12-01 (estimated)
Study Completion	2028-12-31 (estimated)
Updated on ClinicalTrials.gov	2023-12-22